This is a working overview of Aib substitution, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-10-27 and is reviewed periodically as new material appears.
Large randomised trials in adults with type 2 diabetes and in adults with obesity have reported reductions in body weight and improvements in several cardiovascular risk markers. One outcome trial found a lower incidence of major adverse cardiovascular events in participants with diabetes and established cardiovascular disease. Gastrointestinal effects such as nausea and vomiting are the most frequently reported adverse events and often diminish over time. Changes in lean body mass during weight loss are an area of ongoing investigation. Effects in adolescents and in pregnancy are less well characterised, and current labelling advises against use during pregnancy.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released after nutrient intake. The molecule contains 31 amino acid residues and differs from the native sequence at several positions. A non-natural residue at position eight resists the enzyme that normally truncates the hormone, while a lysine-linked fatty diacid side chain promotes binding to serum albumin. These two modifications extend the circulating half-life from minutes to roughly one week. The peptide is produced by solid-phase synthesis followed by selective acylation, and its identity and purity are confirmed by spectrometric and chromatographic techniques.
The primary target is the GLP-1 receptor, a class B G protein-coupled receptor expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises intracellular cyclic AMP, which potentiates glucose-dependent insulin secretion and lowers glucagon release when blood glucose is elevated. Signalling in the hypothalamus and brainstem is associated with reduced appetite and slower gastric emptying. Because the insulinotropic effect depends on prevailing glucose levels, the hypoglycaemic risk of the peptide alone is described as low in most study settings. The relative contribution of peripheral and central actions remains an active research question.
Identity and purity are usually assessed by reverse-phase high-performance liquid chromatography coupled to mass spectrometry. Retention time and observed mass are compared against a reference standard run under identical conditions. Impurity profiles reveal deamidation products, oxidized methionine variants, and truncated fragments that arise during synthesis or storage. Peptide mapping through enzymatic digestion confirms the primary sequence, while amino acid analysis offers an independent check on overall composition.
Stability studies examine how temperature, pH, and moisture influence degradation rates over time. In aqueous solution, hydrolysis and deamidation accelerate as pH moves away from mildly acidic conditions. Light exposure and residual metal ions can also trigger oxidation of susceptible residues. Accelerated aging at elevated temperature is used to estimate shelf life, though extrapolation to room temperature carries uncertainty because individual degradation pathways do not always scale predictably.
Lyophilized semaglutide powder is typically held at minus twenty degrees Celsius for long-term storage. At that temperature, solid-state degradation reactions proceed slowly and the peptide remains intact for extended periods. Repeated freeze-thaw cycles are best avoided because they promote aggregation and can shift the proportion of monomeric peptide present. Working aliquots are often prepared so that each portion is thawed only once, and desiccant is placed inside the vial to limit moisture uptake.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Acylated GLP-1 receptor agonist | 31-residue synthetic peptide |
| Molecular formula | C187H291N45O59 | established for the free peptide |
| Appearance | White to off-white powder | as supplied before formulation |
| Solubility | Freely soluble in water | aqueous buffers near neutral pH |
| Typical storage | 2 to 8 degrees Celsius, protected from light | powder and solution forms differ in shelf life |
Semaglutide is a synthetic peptide that acts as an agonist at the glucagon-like peptide-1 receptor. It is a structural analogue of human GLP-1(7-37), modified to resist enzymatic degradation by dipeptidyl peptidase-4. The peptide backbone contains alpha-aminoisobutyric acid at position 8, a substitution that stabilises the helix and slows cleavage. A fatty diacid side chain attached through a linker at lysine 34 promotes binding to serum albumin, which extends the circulating half-life. These two modifications together allow less frequent administration than native GLP-1 requires.
Activation of the GLP-1 receptor couples to Gs signalling and raises intracellular cyclic AMP in pancreatic beta cells. The resulting insulin release depends on prevailing glucose concentrations, so the effect is greater when glucose is elevated. Receptor engagement also suppresses glucagon secretion and slows gastric emptying, which flattens post-meal glucose excursions. In the central nervous system, signalling in hypothalamic and brainstem regions is associated with reduced appetite and lower energy intake. Studies continue to examine effects on cardiac, renal and hepatic endpoints; whether those benefits are independent of weight change remains an open question.
Semaglutide is a synthetic peptide analogue of glucagon-like peptide-1, a gut hormone released by intestinal L cells after food intake. The natural hormone acts on pancreatic and central receptors but is degraded within minutes by dipeptidyl peptidase-4 and other peptidases. Semaglutide belongs to the class of long-acting GLP-1 receptor agonists, a group distinguished by structural changes that slow breakdown and extend circulation time. Its development followed earlier short-acting analogues and reflects a general strategy in peptide drug design: preserve receptor activity while blocking proteolytic clearance.
Three structural changes define the molecule. At position 8 an alpha-aminoisobutyric acid residue replaces alanine, which blocks dipeptidyl peptidase-4 cleavage. At position 34 arginine replaces lysine, and at position 26 a lysine carries a C18 fatty diacid attached through a short linker. The fatty chain binds serum albumin, and this albumin association reduces renal filtration and enzymatic attack. The unchanged backbone retains the receptor contacts that produce signalling. The free base has the formula C187H291N45O59 and a molecular weight near 4114 daltons.
Receptor activation follows the canonical Gs pathway: binding increases intracellular cyclic AMP, which promotes protein kinase A activity. In pancreatic beta cells this amplifies glucose-dependent insulin release, so secretion rises when blood glucose is high and changes little when it is low. The same signalling suppresses glucagon release from alpha cells and slows gastric emptying. Receptors in the hypothalamus and brainstem are thought to contribute to reduced appetite and lower energy intake. Which of these effects dominates clinical outcomes remains an area of active study.
Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.
The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.
Reverse-phase high-performance liquid chromatography is the standard method for purity assessment, separating the peptide from truncated or oxidized variants. Mass spectrometry confirms molecular mass and detects modifications, while ultraviolet absorbance near 280 nanometers supports concentration measurement through tryptophan and tyrosine residues. Circular dichroism can indicate secondary structure, though the peptide is largely helical in solution, and ion-exchange chromatography resolves charge variants. Purity values above 95 percent are typical for research-grade material. Stability studies track degradation over time under defined conditions.
Lyophilized semaglutide is typically stored at temperatures between minus 20 and minus 80 degrees Celsius for long-term preservation. Short-term storage at 2 to 8 degrees Celsius is common for working aliquots. Repeated freeze-thaw cycles can degrade the peptide and are usually avoided. The molecule is hygroscopic in its solid form, so containers should remain sealed with desiccant. Solutions are less stable than powders and are generally prepared fresh. Light exposure is limited because aromatic residues can undergo photo-oxidation.
Semaglutide dissolves readily in water and in aqueous buffers near neutral pH. Solubility decreases near the isoelectric point, where net charge is minimal. Common laboratory solvents include phosphate-buffered saline and dilute ammonium bicarbonate. Strongly acidic or basic conditions may accelerate hydrolysis. Working concentrations are usually prepared by diluting a concentrated stock. Vial surfaces can adsorb small amounts of peptide at low concentrations, so carrier proteins or low-binding tubes are sometimes used.
An important task within the realm of food safety is the elimination of microorganisms responsible for food-borne illness. Food and waterborne diseases still pose a serious health concern, with hundreds of outbreaks reported per year since 1971 in the United States alone. The risk of these diseases has risen throughout the years, mainly due to the mishandling of raw food, poor sanitation, and poor socioeconomic conditions. In addition to diseases caused by direct infection by pathogens, some food borne diseases are caused by the presence of toxins produced by microorganisms in food. There are five main types of microbial pathogens which contaminate food and water: viruses, bacteria, fungi, pathogenic protozoa and helminths. Several bacteria, such as E. coli, Clostridium botulinum, and Salmonella enterica, are well-known and are targeted for elimination via various industrial processes. Though bacteria are often the focus of food safety processes, viruses, protozoa, and molds are also known to cause food-borne illness and are of concern when designing processes to ensure food safety. Although the goal of food safety is to eliminate harmful organisms from food and prevent food-borne illness, detecting said organisms is another important function of food safety mechanisms.
== Misery Index == Bloomberg's Misery Index 2019 ranked Thailand as the world's "least miserable" economy. The index is calculated as the sum of a country's inflation and unemployment rates. In 2019, Bloomberg again took a swipe at Thai statistics: "Thailand again claimed the title of the 'least miserable' economy, though the government’s unique way of tallying unemployment makes it less noteworthy...." Singapore was ranked as the third "least miserable" and Malaysia, sixth. Bloomberg's Misery Index 2017 ranked Thailand 65 of 65 nations (65=least miserable, 1=most miserable). The index measures the unemployment rate coupled with the inflation rate. Bloomberg commented that "The least miserable country is once again Thailand—in large part due to its unique way of calculating employment..." Other ASEAN nations were ranked: Singapore, 64; Malaysia, 55; Vietnam, 54; Philippines, 37; Indonesia, 23. Bloomberg's Misery Index 2016 ranked Thailand 63 of 63 nations (63=least miserable, 1=most miserable). The index measures the unemployment rate coupled with the inflation rate.
This is a species differing in many particulars from that generally known, and is a much larger bird, standing higher on its legs and having the neck longer than in the common one. Total length seven feet two inches. The bill is not greatly different from that of the common Cassowary; but the horny appendage, or helmet on top of the head, in this species is totally wanting: the whole of the head and neck is also covered with feathers, except the throat and fore part of the neck about half way, which are not so well feathered as the rest; whereas in the common Cassowary the head and neck are bare and carunculated as in the turkey. The plumage in general consists of a mixture of brown and grey, and the feathers are somewhat curled or bent at the ends in the natural state: the wings are so very short as to be totally useless for flight, and indeed, are scarcely to be distinguished from the rest of the plumage, were it not for their standing out a little. The long spines which are seen in the wings of the common sort, are in this not observable,—nor is there any appearance of a tail. The legs are stout, formed much as in the Galeated Cassowary, with the addition of their being jagged or sawed the whole of their length at the back part.
Inosine 5′-monophosphate dehydrogenase (IMPDH) is a purine biosynthetic enzyme that catalyzes the nicotinamide adenine dinucleotide (NAD+)-dependent oxidation of inosine monophosphate (IMP) to xanthosine monophosphate (XMP), the first committed and rate-limiting step towards the de novo biosynthesis of guanine nucleotides from IMP. IMPDH is a regulator of the intracellular guanine nucleotide pool, and is therefore important for DNA and RNA synthesis, signal transduction, energy transfer, glycoprotein synthesis, as well as other processes that are involved in cellular proliferation.
Sources: en.wikipedia.org
Silicon nanoparticles strength and hardness are four times more than the value of the bulk material. The resistance to pressure applied can be attributed to the line defects inside the particles as well as a dislocation that provides strengthening of the mechanical properties of the nanomaterial. Furthermore, the addition of nanoparticles strengthens a matrix because the pinning of particles inhibits grain growth. This refines the grain, and hence improves the mechanical properties. However, not all additions of nanomaterials lead to an increase in properties for example nano-Cu. But this is attributed to the inherent properties of the material being weaker than the matrix. Nonmetallic nanoparticles and nanomaterials: Size-dependent behavior of mechanical properties is still not clear in the case of polymer nanomaterials however, in one research by Lahouij they found that the compressive moduli of polystyrene nanoparticles were found to be less than that of the bulk counterparts. This can be associated with the functional groups being hydrated. Furthermore, nonmetallic nanomaterials can lead to agglomerates forming inside the matrix they are being added to and hence decrease the mechanical properties by leading to fracture under even low mechanical loads, such as the addition of CNTs. The agglomerates will act as slip planes as well as planes in which cracks can easily propagate (9). However, most organic nanomaterials are flexible and these and the mechanical properties such as hardness etc. are not dominant.
Evans' successor Lawrence Quincy Mumford took over in 1953. During his tenure, lasting until 1974, Mumford directed the initiation of construction of the James Madison Memorial Building, the third Library of Congress building on Capitol Hill. Mumford led the library during the government's increased educational spending. The library was able to establish new acquisition centers abroad, including in Cairo and New Delhi. In 1967, the library began experimenting with book preservation techniques through a Preservation Office. This has developed as the most extensive library research and conservation effort in the United States. During Mumford's administration, the last significant public debate occurred about the Library of Congress's role as both a legislative and national library. Asked by Joint Library Committee chairman Senator Claiborne Pell (D-RI) to assess operations and make recommendations, Douglas Bryant of Harvard University Library proposed several institutional reforms. These included expanding national activities and services and various organizational changes, all of which would emphasize the library's federal role rather than its legislative role. Bryant suggested changing the name of the Library of Congress, a recommendation rebuked by Mumford as "unspeakable violence to tradition." The debate continued within the library community for some time.
==== Inflammatory bowel diseases ==== There is a genetic association between GPX4 and Crohn's disease. Subsequent study found that small intestinal epithelial cells (IECs) from Crohn's disease patient samples show reduced GPX4 expression and activity and lipid peroxidation. The same study found that dietary lipids in Western diets such as the PUFA arachidonic acid can trigger enteritis resembling Crohn's disease in a mouse model.
Sources: en.wikipedia.org
=== Formation of one bond === The (1,5) or (3,4) bond can be formed by the reaction of an imidate and an α-aminoaldehyde or α-aminoacetal. The example below applies to imidazole when R1 = R2 = hydrogen.
=== Development and key milestones === Early discoveries in the 1990s included fullerene derivatives mimicking superoxide dismutase (SOD). The 2000s saw the term "nanozyme" formalized and applications expand, such as nanoceria preventing retinal degeneration and peroxidase-like activity in ferromagnetic nanoparticles for immunoassays. The 2010s brought numerous reviews and applications, including colorimetric assays, tumor visualization, and anti-biofouling. Key books and reviews emerged, summarizing progress. In the 2020s, nanozymes advanced in therapeutic applications, such as single-atom nanozymes for sepsis and tumor therapy. Strategies like data-informed discovery and machine learning aided discovery, and applications in treating conditions like Parkinson's disease, inflammatory bowel disease, stroke and traumatic brain injury were reported. Nanozymes were recognized as one of IUPAC's Top Ten Emerging Technologies in Chemistry in 2022. Nanozyme is among the Top 10 Emerging Technologies of 2025 Summer Davos. A monograph entitled nanozymes was published in Chinese (《纳米酶》). Nanozyme-enhanced implants were developed.
The rapid Anglo-Norman conquest proved more important than it seemed. The island occupied a key strategic position on the maritime lanes to the Holy Land, whose occupation by the Christians could not continue without support from the sea. Shortly after the conquest, Cyprus was sold to the Knights Templar and it was subsequently acquired, in 1192, by Guy de Lusignan and became a stable feudal kingdom. It was only in 1489 that the Venetians acquired full control of the island, which remained a Christian stronghold until the fall of Famagusta in 1571.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by dipeptidyl peptidase-4 and neutral endopeptidases. Semaglutide carries a non-natural amino acid at position eight that blocks that cleavage, and a fatty diacid side chain that binds albumin. The result is a much longer duration of action than the native hormone.
The fatty diacid chain associates strongly with serum albumin, which keeps the peptide in circulation and shields it from rapid renal clearance. Bound peptide is released gradually, producing a sustained receptor signal. This mechanism also reduces the peak-to-trough variation seen with shorter-acting analogues.
The balance between peripheral receptor activation and signalling in the central nervous system is not fully resolved. The extent to which slowed gastric emptying accounts for reduced energy intake, compared with direct effects on appetite circuits, is debated. Long-term effects on lean mass and on tissues outside the gut and brain are still under study.
Manufacturers commonly state multi-year stability when the powder is kept dry and frozen. Actual shelf life depends on residual moisture, vial sealing, and storage temperature. A re-test by chromatography is the only way to confirm remaining purity.